US Patent 7750165 Metaxalone polymorphs
Patent 7750165 was granted and assigned to Fresenius Kabi Oncology PLC on July, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+445 characters)
Article
Patent abstract
The invention provides two crystalline forms A and B of the skeletal muscle relaxant and anxiolytic agent, Metaxalone of formula (I), and a process for preparation thereof. The two crystalline forms A and B are bioavailable. The invention further provides pharmaceutical compositions comprising the two bioavailable crystalline forms, useful for the relief of discomforts associated with acute, painful musculoskeletal conditions.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Jayanta Chattopadhyay0
Jyan Shankar Mahanty0
Manoj Kumar Singh0
Moloy Mitra0
Subrata Sarkar0
Susanta Hazra0
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07750165 Metaxalone polymorphs US Patent 7750165 Metaxalone polymorphs
Infobox
Patent Number
077501650
Patent Number
77501650
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077501650
Date of Patent
July 6, 2010
0Patent Application Number
116479740
Date Filed
December 29, 2006
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07750165 Metaxalone polymorphs
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07750165
Date of patent
July 6, 2010
Patent application number
11647974
Date Filed
December 29, 2006
Patent primary examiner
Find more entities like US Patent 7750165 Metaxalone polymorphs
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
